Research Paper Volume 11, Issue 2 pp 649—662
A novel six-microRNA-based model to improve prognosis prediction of breast cancer
Figure 8. Comparisons of the prognostic accuracy at 5-years using time-dependent receiver operating characteristic curves in the six-miRNA signature with single miRNA (A), the six-miRNA signature with clinical risk factors (B), and the six-miRNA-based prognostic model with six-miRNA signature, TNM stage (C).